CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

13 hedge funds and large institutions have $126K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

4% less capital invested

Capital invested by funds: $132K → $126K (-$5.33K)

93% less call options, than puts

Call options by funds: $174K | Put options by funds: $2.49M

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$174K
Puts
$2.49M
Net Calls
Net Calls Change

Top Buyers

1
+$14.1K
2
+$2K
3
+$1.78K
4
UBS Group
UBS Group
Switzerland
+$1.12K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$306

Top Sellers

1
-$1K
2
-$730
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$45.8K
2
$42.5K
3
$14.7K
4
$12.7K
5
$2K
6
$2K
7
$2K
8
$1.43K
9
$1.12K
10
$1K
11
$627
12
$280
13
$191
14
$3
15
–